Sign In
to Vote &
Create Storyboards.
 

Akorn's Restatement Drives Investors Nuts

Wall Street Journal - 27 Apr 2015 19:51
Generic-drug maker Akorn has run into accounting issues. In today's frenzied deal market, though, that might attract interest.
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard